Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »
Prostate cancer is the most common cancer in men in the UK. The disease usually develops slowly and there may be no signs for many years. Symptoms don’t usually appear until the cancer has grown large enough to put pressure on the urethra. This can cause problems with urination, such as needing to pee more… Read More »
People with prostate cancer are at risk of metastatic tumors forming. A newly developed test can assess this risk more quickly than existing tests and is also cheaper to run. Researchers explain the benefits of a new test that measures the risk of metastasis in prostate cancer. According to the National Cancer Institute, about 11.2… Read More »
Jen BabakhanDec 07 Jim O’Connell prides himself on being health conscious in every way, so when he received a prostate cancer diagnosis—and the news that it was aggressive—he was shocked Courtesy Jim O’ConnellWhen Jim O’Connell moved to New York City in 1997, he signed up with a new doctor who ordered a basic panel of… Read More »